Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001214659-24-004305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-07 | AQST | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +242.6K | 883.3K | +38% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +363.9K | 363.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | A | A | 242,600 | $0.00 | 883,302 | D | — | — | (F1) The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-07 | A | A | 363,900 | $0.00 | 363,900 | D | $5.68 · — to 2034-03-07 | 363,900 Common Stock | (F2) The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |